Möchten Sie immer auf dem neuesten Stand bleiben?

Rapid expansion in clinical applications, rising demand for genomic diagnostics, and increased investment in CRISPR-based therapeutics are fueling demand.

Increasing regulatory requirements and the need for data accuracy are driving demand for validation, calibration, and standardization in life sciences.

According to BCC Research, growing demand for compact, lightweight, and high-performance electronic devices is driving strong growth in the FPCB market.

Increasing adoption of cloud platforms is enabling scalable data analysis, accelerating genomics research, and streamlining drug development workflows.

The study highlights expanding applications in water treatment, pharmaceuticals, and chemical processing as key drivers of global market growth.

A new report from BCC Research, AI in Higher Education: Global Market, provides a comprehensive qualitative analysis of AI adoption trends.

The neuroprotective agents market in North America is growing at approximately 4.5% CAGR through 2030, with AI-driven approaches.

The global market for neuroprotective agents was valued at $41.2 billion in 2024 and is expected to reach $60.9 billion by the end of 2030.

global industrial chains market was valued at $4.1 billion in 2024 and is expected to reach $5.2 billion by the end of 2030.

Global market for technologies for long-term care and home healthcare was valued at $43.4 billion in 2024 and is expected to reach $64.8 billion by 2030.